Use of LAIV (live attenuated influenza virus) in healthy adults ages 18 to 65 reduced antibiotic use by 43% to 47%.
[ Get More Details ]
Potential cost effectiveness of shingles vaccines
The projected cost-effectiveness of a shingles vaccine for adults age 60 and older was estimated at $15,390 – $22,474 from the payer perspective, and $14,450 to $21,524 from the societal… [ Get More Details ]
Immunization significantly lowers rates of leading infectious diseases